Evaluation of Prototype Lenses With Experimental UV/HEV Blocker

Not Applicable

Completed

• Conditions: Visual Acuity
• Interventions: Device: TRP-200; Device: JJVC Marketed Contact Lens

• Registration Number: NCT04885296
• Lead Sponsor: Johnson & Johnson Vision Care, Inc.

Brief Summary

This is a bilateral, 2-week dispensing, randomized, controlled, subject-masked, 2×2 crossover study to evaluate the clinical performance of prototype contact lenses with experimental UV/HEV-blocker.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-05-10
• Study First Submitted: 2021-05-10
• Study First Submitted QC: 2021-05-10
• Study First Posted: 2021-05-13
• Primary Completion: 2021-08-09
• Study Completion: 2021-08-09
• Status Verified: 2022-08
• Results First Submitted: 2022-08-08
• Results First Submitted QC: 2022-08-08
• Last Update Submitted: 2022-08-08
• Results First Posted: 2022-09-01
• Last Update Posted: 2022-09-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 228

Inclusion Criteria

• Potential subjects must satisfy all of the following criteria to be enrolled in the study:

  1. Read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
  2. Appear able and willing to adhere to the instructions set forth in this clinical protocol.
  3. Be between 18 and 39 (inclusive) years of age at the time of screening.
  4. By self-report, habitually wear spherical silicone hydrogel soft contact lenses in both eyes in a daily reusable or daily disposable wear modality (i.e. not extended wear modality). Habitual wear is defined as a minimum of 6 hours of wear per day, for a minimum of 5 days per week during the past 30 days.
  5. Have a habitual contact lens prescription that is current within the prior 6 months, and they must have worn that prescription for at least 2 weeks prior to entering the study.
  6. The subject's vertex corrected spherical equivalent distance refraction must be in the range of -1.00 through -6.00 D (except -5.00 D) in both eyes.
  7. The subject's refractive cylinder must be 1.00 D or less.
  8. The subject must have best corrected visual acuity of 20/25 or better in each eye.

Exclusion Criteria

• Potential subjects who meet any of the following criteria will be excluded from participating in the study:

  1. Be currently pregnant or lactating.
  2. Have any ocular or systemic allergies or diseases that may interfere with contact lens wear.
  3. Have any autoimmune disease or use of medication, which may interfere with contact lens wear. Habitual medications used by successful soft contact lens wearers are considered acceptable.
  4. Have any previous, or planned, ocular or interocular surgery (e.g., radial keratotomy, PRK, LASIK, etc.).
  5. Be currently wearing lenses in a monovision, multi-focal, toric, or extended wear modality.
  6. Have participated in a contact lens or lens care product clinical trial within 14 days prior to study enrollment.
  7. Be an employee (e.g., Investigator, Coordinator, Technician) or immediate family member of an employee (including partner, child, parent, grandparent, grandchild or sibling of the employee or their spouse) of the clinical site.
  8. Have a history of binocular vision abnormality or strabismus.
  9. Have any infectious disease (e.g., hepatitis, tuberculosis) or contagious immunosuppressive diseases (e.g., HIV) by self-report.
  10. Have any Grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA classification scale, any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that may contraindicate contact lens wear.
  11. Have any ocular infection.
  12. Have any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
  13. Have entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, or aphakia.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Control/Test	TRP-200	Eligible subjects will be randomized into one of two possible lens wear sequences, Control/Test.
Test/Control	TRP-200	Eligible subjects will be randomized into one of two possible lens wear sequences, Test/Control.
Test/Control	JJVC Marketed Contact Lens	Eligible subjects will be randomized into one of two possible lens wear sequences, Test/Control.
Control/Test	JJVC Marketed Contact Lens	Eligible subjects will be randomized into one of two possible lens wear sequences, Control/Test.

Primary Outcome Measures

Name	Time	Method
Overall Quality of Vision Score	2-Week Follow-up	Overall quality of vision scores were assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. The average CLUE vision score for each lens type was reported.

Secondary Outcome Measures

Name	Time	Method
Overall Comfort Scores	2-Week Follow-up	Overall comfort scores were assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. The average CLUE comfort score for each lens type was reported.
Overall Handling Scores	2-Week Follow-up	Overall handling scores were assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. The average CLUE handling score for each lens type was reported.

Trial Locations

Locations (12)

Tallahassee Eye Center; 🇺🇸 Tallahassee, Florida, United States

Flora Chen Poveda, OD, PA; 🇺🇸 Orange Park, Florida, United States

Complete Eye Care of Medina; 🇺🇸 Medina, Minnesota, United States

Professional Vision Care, Inc.; 🇺🇸 Westerville, Ohio, United States

Dr. Debbie H. Kim, OD; 🇺🇸 Closter, New Jersey, United States

Gulf Coast Vision Center, Inc.; 🇺🇸 Houston, Texas, United States

Visual Eyes; 🇺🇸 Roswell, Georgia, United States

Dr. James Weber & Associates, PA; 🇺🇸 Jacksonville, Florida, United States

Birmingham Vision Care; 🇺🇸 Bloomfield Township, Michigan, United States

Frazier Vision, Inc.; 🇺🇸 Tyler, Texas, United States

Optometry Group, LLC; 🇺🇸 Memphis, Tennessee, United States

Botetourt Eyecare, LLC; 🇺🇸 Salem, Virginia, United States